CoChat

PD‐1 suppresses TCR‐CD8 cooperativity during T‐cell antigen recognition

Open access

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Abstract

Despite the clinical success of blocking its interactions, how PD-1 inhibits T-cell activation is incompletely understood, as exemplified by its potency far exceeding what might be predicted from its affinity for PD-1 ligand-1 (PD-L1). This may be partially attributed to PD-1's targeting the proximal signaling of the T-cell receptor (TCR) and co-stimulatory receptor CD28 via activating Src homology region 2 domain-containing phosphatases (SHPs). Here, we report PD-1 signaling regulates the initial TCR antigen recognition manifested in a smaller spreading area, fewer molecular bonds formed, and shorter bond lifetime of T cell interaction with peptide-major histocompatibility complex (pMHC) in the presence than absence of PD-L1 in a manner dependent on SHPs and Leukocyte C-terminal Src kinase. Our results identify a PD-1 inhibitory mechanism that disrupts the cooperative TCR-pMHC-CD8 trimolecular interaction, which prevents CD8 from augmenting antigen recognition, explaining PD-1's potent inhibitory function and its value as a target for clinical intervention.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-22965-9

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 PD-1 inhibits T-cell spreading on surface co-presenting pMHC and PD-L1. a Representative images by reflection interference contrast microscopy (RICM). PDCD1 −/− P14 transgenic CD8+ T cells re-expressing PD-1 (left column) or vehicle (right column) were added onto glass coverslip coated with BSA (1st row), gp33:H2-Db (2nd row), gp33:H2-Db and PD-L1 (3rd row), or OVA:H2-Kb and PD-L1 (4th row). Cell spreading was imaged by RICM 20 min after their addition. b Quantification of a showing reduced spreading of PD-1-expressing cells on surfaces co-presenting gp33:H2-Db and PD-L1 (n = 31, 31, 32, and 31 cells). c Quantification of a showing no change in spreading area of vehicle-expressing cells on surfaces co-presenting gp33:H2-Db and PD-L1 (n = 28, 37, 68, and 27 cells). d Representative RICM images showing the spreading of in vitro activated wild-type P14 transgenic CD8+ T cells expressing endogenous PD-1 20 min after adding onto glass coverslip coated with gp33:H2-Db (top) or gp33:H2-Db and PD-L1 (bottom). e Quantification of d showing reduced spreading of endogenous PD-1-expressing cells on surfaces co-presenting gp33:H2-Db and PD-L1 (n = 56 and 56 cells). f Representative RICM images showing the spreading of in vitro activated wild-type P14 transgenic CD8+ T cells 20 min after adding onto glass coverslip coated with BSA, gp33:H2-Db, gp33:H2-Db and ICAM-1, or OVA:H2-Kb and ICAM-1 (indicated). g Quantification of f showing larger spreading area on surfaces co-presenting gp33:H2-Db and ICAM-1 than on gp33:H2-Db or ICAM-1 surfaces alone (n = 62, 83, 61, and 56 cells). Data are presented by box-whisker plots with the center line labels median, the box contains the two middle quantiles, and the whiskers mark the min and the max. p values were calculated using Mann–Whitney test by comparing each group with BSA control or two groups as labeled.
Fig. 1 PD-1 inhibits T-cell spreading on surface co-presenting pMHC and PD-L1. a Representative images by reflection interference contrast microscopy (RICM). PDCD1 −/− P14 transgenic CD8+ T cells re-expressing PD-1 (left column) or vehicle (right column) were added onto glass coverslip coated with BSA (1st row), gp33:H2-Db (2nd row), gp33:H2-Db and PD-L1 (3rd row), or OVA:H2-Kb and PD-L1 (4th row). Cell spreading was imaged by RICM 20 min after their addition. b Quantification of a showing reduced spreading of PD-1-expressing cells on surfaces co-presenting gp33:H2-Db and PD-L1 (n = 31, 31, 32, and 31 cells). c Quantification of a showing no change in spreading area of vehicle-expressing cells on surfaces co-presenting gp33:H2-Db and PD-L1 (n = 28, 37, 68, and 27 cells). d Representative RICM images showing the spreading of in vitro activated wild-type P14 transgenic CD8+ T cells expressing endogenous PD-1 20 min after adding onto glass coverslip coated with gp33:H2-Db (top) or gp33:H2-Db and PD-L1 (bottom). e Quantification of d showing reduced spreading of endogenous PD-1-expressing cells on surfaces co-presenting gp33:H2-Db and PD-L1 (n = 56 and 56 cells). f Representative RICM images showing the spreading of in vitro activated wild-type P14 transgenic CD8+ T cells 20 min after adding onto glass coverslip coated with BSA, gp33:H2-Db, gp33:H2-Db and ICAM-1, or OVA:H2-Kb and ICAM-1 (indicated). g Quantification of f showing larger spreading area on surfaces co-presenting gp33:H2-Db and ICAM-1 than on gp33:H2-Db or ICAM-1 surfaces alone (n = 62, 83, 61, and 56 cells). Data are presented by box-whisker plots with the center line labels median, the box contains the two middle quantiles, and the whiskers mark the min and the max. p values were calculated using Mann–Whitney test by comparing each group with BSA control or two groups as labeled.CC BY · PubMed Central
Fig. 2 2D kinetic analysis of negative cooperativity. a Schematic of the micropipette assay (top) and the molecules to be analyzed (middle). A T cell expressing TCR, CD8 and PD-1 (right) was tested against three RBCs bearing pMHC, PD-L1, or both (mix) in random order (left) to generate three adhesion frequencies (Pa’s), one for each RBC after 30-50 repeated touches with the T cell. The bottom row shows the workflow of using the three Pa’s to determine the bond numbers (<n> ’s) and the differential bond number (Δ <n>). b, d Representative Pa’s of individual in vitro activated P14 CD8+ T cells binding to RBCs coated with gp33:H2-Db, PD-L1, or both at 5-s (b) or 0.5-s (d) contact time. Data points measured by testing the same T cell against three RBCs bearing different ligands are connected by a dashed line. c, e Comparisons of predicted and measured <n>’s from b (c) and d (e), respectively. f Normalized change of bond number (Δ<n>/<n>pred). The reduction of bond formation observed at 5-s contact tests (n = 17 cells) was abolished when the contact time was shortened to 0.5 s (n = 8 cells). g Representative Pa’s of individual activated PDCD1−/− P14 CD8+ T cells to RBCs bearing gp33:H2-Db, PD-L1, or both at 5-s contacts. h Comparison of predicted and measured <n>’s from g. i Δ<n>/<n>pred showing the reduction of bond formation observed when PD-1 expressing cells were used was abolished when PDCD1−/− cells were used (n = 16 cells). Data are presented by box-whisker plots with the center line labels median, the box contains the two middle quantiles, and the whiskers mark the min and the max. p values were calculated using paired Student’s t test (c, e, h) or Mann–Whitney test (f, i).
Fig. 2 2D kinetic analysis of negative cooperativity. a Schematic of the micropipette assay (top) and the molecules to be analyzed (middle). A T cell expressing TCR, CD8 and PD-1 (right) was tested against three RBCs bearing pMHC, PD-L1, or both (mix) in random order (left) to generate three adhesion frequencies (Pa’s), one for each RBC after 30-50 repeated touches with the T cell. The bottom row shows the workflow of using the three Pa’s to determine the bond numbers (<n> ’s) and the differential bond number (Δ <n>). b, d Representative Pa’s of individual in vitro activated P14 CD8+ T cells binding to RBCs coated with gp33:H2-Db, PD-L1, or both at 5-s (b) or 0.5-s (d) contact time. Data points measured by testing the same T cell against three RBCs bearing different ligands are connected by a dashed line. c, e Comparisons of predicted and measured <n>’s from b (c) and d (e), respectively. f Normalized change of bond number (Δ<n>/<n>pred). The reduction of bond formation observed at 5-s contact tests (n = 17 cells) was abolished when the contact time was shortened to 0.5 s (n = 8 cells). g Representative Pa’s of individual activated PDCD1−/− P14 CD8+ T cells to RBCs bearing gp33:H2-Db, PD-L1, or both at 5-s contacts. h Comparison of predicted and measured <n>’s from g. i Δ<n>/<n>pred showing the reduction of bond formation observed when PD-1 expressing cells were used was abolished when PDCD1−/− cells were used (n = 16 cells). Data are presented by box-whisker plots with the center line labels median, the box contains the two middle quantiles, and the whiskers mark the min and the max. p values were calculated using paired Student’s t test (c, e, h) or Mann–Whitney test (f, i).CC BY · PubMed Central
Fig. 3 Negative cooperativity depends on signaling of both PD-1 and TCR. a, b Comparisons of normalized numbers of single-ligand bonds formed between PD-L1 (a, n = 42 and 14 cells) or pMHC (b, n = 27 and 14 cells) coated RBCs and in vitro activated T cells that were not treated (NT) or treated with 20 µM SHP1 and SHP2 inhibitor NSC87877 (SHP In). c Representative results comparing predicted and measured <n>’s determined from binding of NSC87822-treated T cells to RBCs bearing pMHC, PD-L1, or both. d Comparison of normalized bond reduction (Δ<n>/<n>pred) between the not treated and NSC87877-treated groups (n = 17 and 14 cells). e–h Similar to a–d except that the not treated group was replaced by the DMSO group and NSC87877 was replaced by the Lck inhibitor (2 µM). n = 14 and 15 cells in e. n = 14 and 16 cells in f. n = 14 and 16 cells in h. Data are presented by box-whisker plots with the center line labels median, the box contains the two middle quantiles, and the whiskers mark the min and the max. p values were calculated using paired t-test (c, g) or Mann–Whitney test (the rest).
Fig. 3 Negative cooperativity depends on signaling of both PD-1 and TCR. a, b Comparisons of normalized numbers of single-ligand bonds formed between PD-L1 (a, n = 42 and 14 cells) or pMHC (b, n = 27 and 14 cells) coated RBCs and in vitro activated T cells that were not treated (NT) or treated with 20 µM SHP1 and SHP2 inhibitor NSC87877 (SHP In). c Representative results comparing predicted and measured <n>’s determined from binding of NSC87822-treated T cells to RBCs bearing pMHC, PD-L1, or both. d Comparison of normalized bond reduction (Δ<n>/<n>pred) between the not treated and NSC87877-treated groups (n = 17 and 14 cells). e–h Similar to a–d except that the not treated group was replaced by the DMSO group and NSC87877 was replaced by the Lck inhibitor (2 µM). n = 14 and 15 cells in e. n = 14 and 16 cells in f. n = 14 and 16 cells in h. Data are presented by box-whisker plots with the center line labels median, the box contains the two middle quantiles, and the whiskers mark the min and the max. p values were calculated using paired t-test (c, g) or Mann–Whitney test (the rest).CC BY · PubMed Central
Fig. 4 Negative cooperativity can be explained by the PD-1 suppression of TCR-CD8 cooperativity. a Comparison of normalized numbers of bonds formed between P14 CD8+ T cells and RBCs bearing gp33:H2-Db (n = 15 cells) or gp33:H2-Dbα3A2 (n = 21 cells) at 2-s contact time. b Representative experiment comparing predicted and measured <n>’s determined from binding of T cells to RBCs bearing gp33:H2-Dbα3A2, PD-L1, or both. c Comparison of normalized bond reductions (Δ<n>/<n>pred) between the gp33:H2-Db (n = 17 cells) and gp33:H2-Dbα3A2 (n = 12 cells) groups. d Schematics of the BFP setup (top) and the molecules to be analyzed (bottom). As an advanced version of the micropipette system, the BFP uses a glass bead to present pMHC, PD-L1, or both (left) to interact with the TCR, CD8, PD-1, or all of them (right). e Representative force-time trace recorded in a test cycle of a force-clamp assay. The level of clamped force and the duration of bond lifetime are indicated. f Plots of mean ± s.e.m. lifetime vs. mean force of single bonds of PD-L1, gp33:H2-Db, or gp33:H2-Dbα3A2 interaction with untreated P14 CD8+ T cells and of gp33:H2-Db interaction with Lck inhibitor-treated P14 CD8+ T cells. g Bond lifetime distributions of the molecular interactions in f at 3 pN showing as survival probability in semi-log plots. h–m Comparisons between predicted and measured mean ± s.e.m. bond lifetimes (h, j, l; 3- and 6-pN bins) and their distributions (i, k, m; 3-pN bin). Untreated (h–k) or Lck inhibitor-treated (l, m) CD8+ T cells expressing P14 TCR and PD-1 were analyzed by the force-clamp assay against BFP beads bearing PD-L1 plus gp33:H2-Db (h, i, l, m) or PD-L1 plus gp33:H2-Dbα3A2 (j, k) at 2-s contact time. The predictions were based on the percentages of single-bond events formed by each of the two ligands in each lifetime ensemble, as indicated for each pair of panels (h–j and k–m), which were determined from the ligand densities coated on each group of beads and the TCR and PD-1 expressed on each batch of T cells. The bond lifetime distributions of two single-ligand bonds were also shown in i, k and m for comparison. The weighted sum of these single-specie bond lifetimes (distributions) were used to calculate the predicted lifetime (distribution). For the box-whisker plots in a and c, the center line labels median, the box contains the two middle quantiles, and the whiskers mark the min and the max. p values were calculated using Mann–Whitney test (a, c), paired t-test (b), or standard t-test (h, j, l). The sample sizes of bond lifetime events are summarized in Supplementary Table 1.
Fig. 4 Negative cooperativity can be explained by the PD-1 suppression of TCR-CD8 cooperativity. a Comparison of normalized numbers of bonds formed between P14 CD8+ T cells and RBCs bearing gp33:H2-Db (n = 15 cells) or gp33:H2-Dbα3A2 (n = 21 cells) at 2-s contact time. b Representative experiment comparing predicted and measured <n>’s determined from binding of T cells to RBCs bearing gp33:H2-Dbα3A2, PD-L1, or both. c Comparison of normalized bond reductions (Δ<n>/<n>pred) between the gp33:H2-Db (n = 17 cells) and gp33:H2-Dbα3A2 (n = 12 cells) groups. d Schematics of the BFP setup (top) and the molecules to be analyzed (bottom). As an advanced version of the micropipette system, the BFP uses a glass bead to present pMHC, PD-L1, or both (left) to interact with the TCR, CD8, PD-1, or all of them (right). e Representative force-time trace recorded in a test cycle of a force-clamp assay. The level of clamped force and the duration of bond lifetime are indicated. f Plots of mean ± s.e.m. lifetime vs. mean force of single bonds of PD-L1, gp33:H2-Db, or gp33:H2-Dbα3A2 interaction with untreated P14 CD8+ T cells and of gp33:H2-Db interaction with Lck inhibitor-treated P14 CD8+ T cells. g Bond lifetime distributions of the molecular interactions in f at 3 pN showing as survival probability in semi-log plots. h–m Comparisons between predicted and measured mean ± s.e.m. bond lifetimes (h, j, l; 3- and 6-pN bins) and their distributions (i, k, m; 3-pN bin). Untreated (h–k) or Lck inhibitor-treated (l, m) CD8+ T cells expressing P14 TCR and PD-1 were analyzed by the force-clamp assay against BFP beads bearing PD-L1 plus gp33:H2-Db (h, i, l, m) or PD-L1 plus gp33:H2-Dbα3A2 (j, k) at 2-s contact time. The predictions were based on the percentages of single-bond events formed by each of the two ligands in each lifetime ensemble, as indicated for each pair of panels (h–j and k–m), which were determined from the ligand densities coated on each group of beads and the TCR and PD-1 expressed on each batch of T cells. The bond lifetime distributions of two single-ligand bonds were also shown in i, k and m for comparison. The weighted sum of these single-specie bond lifetimes (distributions) were used to calculate the predicted lifetime (distribution). For the box-whisker plots in a and c, the center line labels median, the box contains the two middle quantiles, and the whiskers mark the min and the max. p values were calculated using Mann–Whitney test (a, c), paired t-test (b), or standard t-test (h, j, l). The sample sizes of bond lifetime events are summarized in Supplementary Table 1.CC BY · PubMed Central
Fig. 5 PD-1’s suppression of TCR-CD8 cooperativity requires CD8–Lck association. Sorted P14 CD8−CD4− (DN) thymocytes were transduced to express CD8 WT or SKSP mutant that abolishes Lck binding, followed by 2D kinetic analysis for negative cooperativity. a Representative CD4 vs CD8 plots of total P14 thymocytes showing the sorting strategy (left and middle) and purity (right) of DN thymocytes. b Representative histogram plot of retroviral-transduced P14 DN thymocytes expressing CD8 WT or SKSP mutant. c Comparison of normalized numbers of bonds formed between RBCs bearing gp33:H2-Db and P14 DN thymocytes transduced to express CD8WT or CD8SKSP (n = 17 and 15 cells) at 2-s contact time. d Comparison of normalized numbers of bonds formed between untransduced, CD8WT, or CD8SKSP P14 DN thymocytes and RBCs bearing gp33:H2-Db (n = 11, 11, and 11 cells) or gp33:H2-Dbα3A2 (n = 10, 10, and 12 cells) at 5-s contact time. e Comparison of normalized bond reductions (Δ<n>/<n>pred) between CD8WT and groups CD8SKSP (n = 16 and 17 cells). Data are presented by box-whisker plots (the center line labels median, the box contains the two middle quantiles, and the whiskers mark the min and the max) with the n values indicating the numbers of cells measured per condition. p values were calculated using Mann–Whitney test.
Fig. 5 PD-1’s suppression of TCR-CD8 cooperativity requires CD8–Lck association. Sorted P14 CD8−CD4− (DN) thymocytes were transduced to express CD8 WT or SKSP mutant that abolishes Lck binding, followed by 2D kinetic analysis for negative cooperativity. a Representative CD4 vs CD8 plots of total P14 thymocytes showing the sorting strategy (left and middle) and purity (right) of DN thymocytes. b Representative histogram plot of retroviral-transduced P14 DN thymocytes expressing CD8 WT or SKSP mutant. c Comparison of normalized numbers of bonds formed between RBCs bearing gp33:H2-Db and P14 DN thymocytes transduced to express CD8WT or CD8SKSP (n = 17 and 15 cells) at 2-s contact time. d Comparison of normalized numbers of bonds formed between untransduced, CD8WT, or CD8SKSP P14 DN thymocytes and RBCs bearing gp33:H2-Db (n = 11, 11, and 11 cells) or gp33:H2-Dbα3A2 (n = 10, 10, and 12 cells) at 5-s contact time. e Comparison of normalized bond reductions (Δ<n>/<n>pred) between CD8WT and groups CD8SKSP (n = 16 and 17 cells). Data are presented by box-whisker plots (the center line labels median, the box contains the two middle quantiles, and the whiskers mark the min and the max) with the n values indicating the numbers of cells measured per condition. p values were calculated using Mann–Whitney test.CC BY · PubMed Central
Fig. 6 PD-1 suppressed antigen-triggered T cell Ca2+ signaling. a, c Heat maps constructed using Ca2+ images from individual cells to show the signal dynamics. Activated PDCD1−/− P14 CD8+ T cells re-expressing PD-1 were loaded with the X-Rhod-1 calcium dye, placed on glass coverslips coated with gp33:H2-Db alone (a, n = 82 cells) or gp33:H2-Db plus PD-L1 (c, n = 47 cells), and imaged under a microscope with a 2-s frame interval for 20–30 min. Each row represents an individual cell aligned by their landing time to the glass surface and sorted from top to bottom with increasing Ca2+ signal strength. The pseudo-color represents normalized Ca2+ signal against base fluorescence. b, d Contour plots of images in a and c at indicated fold-increase. e–g Quantification of a–d showing percentages of cells (mean ± s.e.m.) with calcium peak above indicated levels of fold-increase (e), and box-whisker plots of the peak values (f) and area under curves (AUC) (g) of calcium time courses of individual cells with the center line labeling median, the box containing the two middle quantiles and the whiskers marking the min and the max. p values were calculated using standard t-test (e) or Mann–Whitney test (f, g).
Fig. 6 PD-1 suppressed antigen-triggered T cell Ca2+ signaling. a, c Heat maps constructed using Ca2+ images from individual cells to show the signal dynamics. Activated PDCD1−/− P14 CD8+ T cells re-expressing PD-1 were loaded with the X-Rhod-1 calcium dye, placed on glass coverslips coated with gp33:H2-Db alone (a, n = 82 cells) or gp33:H2-Db plus PD-L1 (c, n = 47 cells), and imaged under a microscope with a 2-s frame interval for 20–30 min. Each row represents an individual cell aligned by their landing time to the glass surface and sorted from top to bottom with increasing Ca2+ signal strength. The pseudo-color represents normalized Ca2+ signal against base fluorescence. b, d Contour plots of images in a and c at indicated fold-increase. e–g Quantification of a–d showing percentages of cells (mean ± s.e.m.) with calcium peak above indicated levels of fold-increase (e), and box-whisker plots of the peak values (f) and area under curves (AUC) (g) of calcium time courses of individual cells with the center line labeling median, the box containing the two middle quantiles and the whiskers marking the min and the max. p values were calculated using standard t-test (e) or Mann–Whitney test (f, g).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Cited by

See all 82

Metadata

Authors
Li, K., Yuan, Z., Lyu, J., Ahn, E., Davis, S. J., Ahmed, R., & Zhu, C.
Affiliations
  • Georgia Institute of Technology (US)
  • Emory University (US)
  • John Radcliffe Hospital (GB)
Corresponding author
Zhu, Cheng
Venue
Nature Communications
Published
2021-05-12
Volume
12
Issue
1
Pages
2746-2746
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3163417555
Cited by
81
References
77
Citations by year
2026: 11 · 2025: 15 · 2024: 18 · 2023: 21 · 2022: 11 · 2021: 5
FWCI
5.22
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA214354, R01CA243486, U01CA250040)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
PD-1, PD-L1, T cell activation, CD28, SHP2, Lck, antigen recognition, T cell receptor signaling, immune checkpoint blockade
MeSH terms
Animals, Calcium, Humans, Lymphocyte Activation, Major Histocompatibility Complex, Mice, Transgenic, Protein Binding, Receptors, Antigen, T-Cell, T-Lymphocytes, Signal Transduction, CD8 Antigens, Lymphocyte Specific Protein Tyrosine Kinase p56(lck), Mice, B7-H1 Antigen, Programmed Cell Death 1 Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PD‐1 suppresses TCR‐CD8 cooperativity during T‐cell antigen recognition. https://app.cochat.ai/papers/10.1038/s41467-021-22965-9
The paper
Li, K., Yuan, Z., Lyu, J., Ahn, E., Davis, S. J., Ahmed, R., & Zhu, C. (2021). PD‐1 suppresses TCR‐CD8 cooperativity during T‐cell antigen recognition. Nature Communications. https://doi.org/10.1038/s41467-021-22965-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.